SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-057530
Filing Date
2023-11-01
Accepted
2023-11-01 16:44:37
Documents
88
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20230930.htm   iXBRL 10-Q 3972216
2 EX-31.1 inva-ex31_1.htm EX-31.1 13946
3 EX-31.2 inva-ex31_2.htm EX-31.2 13948
4 EX-32 inva-ex32.htm EX-32 22469
  Complete submission text file 0000950170-23-057530.txt   16827892

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20230930_pre.xml EX-101.PRE 661924
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20230930_def.xml EX-101.DEF 515225
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20230930_cal.xml EX-101.CAL 106959
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inva-20230930_lab.xml EX-101.LAB 759891
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20230930.xsd EX-101.SCH 103587
82 EXTRACTED XBRL INSTANCE DOCUMENT inva-20230930_htm.xml XML 3655873
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 231368880
SIC: 2834 Pharmaceutical Preparations